Kura Oncology KURA
NASDAQ KURA
$7.73 +0.16 (+2.11%)
At close: Nov 11, 2026 · 4:00 PM EST

Kura Oncology (KURA) Convertible Debt (2014 - 2015)

Updated

Kura Oncology's Convertible Debt was $500,000 in Q4 2014.

Analysis

Kura Oncology (KURA) Convertible Debt (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kura Oncology 695.52 Mn -1.56 Bn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 268,000.00
Jun 30, 2015 307,000.00
Dec 31, 2014 500,000.00
API Access

Kura Oncology Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=KURA&period=max&api_key=YOUR_API_KEY